Market Research Store Has added latest report on "Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 – Asia-Pacific".
Deerfield Beach, FL -- (SBWIRE) -- 08/20/2015 -- Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 – Asia-Pacific" provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data by revenue and volume over the 2006-2020 period for the following countries: Australia, Japan, China and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Research's team of industry experts.
Do Inquiry Before Buying this report:
Information on market size for the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations
Annualized sales data by revenue for the 2006-2020 period and company share data by revenue for 2013
Annualized sales data by volume for the 2006-2020 period
Coverage of key geographies: Australia, Japan, China and India
Reasons to buy
Derive actionable insights from value-volume relationships
Analyze value-volume relationships and provide direction to marketing and sales strategies
Develop market-entry and market-expansion strategies
Identify the key players best positioned to take advantage of opportunities in the Asia-Pacific market
Request For Sample Report Here:
Related news on "Patient Monitoring Devices" from Publisher
Patient Monitoring Technologies Embraced by BRIC Countries
Investments in healthcare infrastructure within BRIC countries are expected to play a significant role in the future growth of the patient monitoring devices market, as medical facilities aspire to achieve Western standards of care, states new research by Research.
The new report* states that during the last decade, various developing countries have exploded into the global healthcare market, as a result of huge population numbers and fast-emerging wealth. Patient monitoring technologies are witnessing a soaring trade as a result of such healthcare system overhauls, and some manufacturing companies are working hard to cash in on this new market.
Until recently, India had very low national healthcare expenditure, but private sector investments have been increasing in the country and improving medical facilities. Large-scale investment by corporate groups in underserved cities has increased the number of hospitals, clinics and diagnostic centers, with major hospital groups such as Fortis Healthcare and Apollo Hospitals announcing expansion plans in India. The addition of new medical facilities provides significant opportunities for growth in the patient monitoring devices market in India, which is expected to grow from a value of $85m in 2012 to $134m in 2019, at a Compound Annual Growth Rate (CAGR) of 7%.
Similarly, China's central government has recently pushed to improve healthcare services, investing $70 billion over the last few years in the construction of hospitals and clinics in regions with inadequate healthcare access. This allows more patients to be seen, therefore increasing the opportunities for patient monitoring devices to be utilized. The 12th Five Year Plan (2011–2015) promises to invest significantly to further expand medical services in China, suggesting that this trend will only continue. Research therefore predicts that the patient monitoring devices market in China will grow from $445m in 2012 to $714 m in 2019, at a CAGR of 7%.
The global patient monitoring devices market was lead by Philips Healthcare and GE Healthcare in 2011, with respective shares of 23% and 13%. Other key players in the patient monitoring market are Mindray Medical International Limited, Draegerwerk AG & Co. KGaA, and Nihon Kohden Corporation. Philips Healthcare's dominant market presence stems from their extensive international presence, with acquisitions of Meditronics in India, Shenzhen Goldway in China and Dixtal Biomedica e Tecnologia (Dixtal) in Brazil, building on the company's product portfolio and strengthening its position in the emerging countries.